Shukra Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 108.84 million compared to INR 462.46 million a year ago. Revenue was INR 122.61 million compared to INR 471.37 million a year ago. Net income was INR 39.86 million compared to INR 39.77 million a year ago. Basic earnings per share from continuing operations was INR 3.64 compared to INR 23.46 a year ago. Diluted earnings per share from continuing operations was INR 3.64 compared to INR 23.46 a year ago.
For the full year, sales was INR 745.73 million compared to INR 588.34 million a year ago. Revenue was INR 773.88 million compared to INR 600.3 million a year ago. Net income was INR 185.37 million compared to INR 44.07 million a year ago. Basic earnings per share from continuing operations was INR 16.93 compared to INR 26.21 a year ago. Diluted earnings per share from continuing operations was INR 16.93 compared to INR 26.21 a year ago.